Equine Sports Council

Controlled Medications Library

ESC MEDICATION CLASSIFICATIONClass C1 - Strictly Controlled - PE Medical

ESC Medication Library · Revision 4

← Medication library · Compare sanctioning bodies

Medication Facts

Performance enhancing
Potentially
Total hours to clear
504
Frequently used
Most Prescribed
ESC ID
PREDNI-0742
Trade names
Meticorten
Drug type
Corticosteroid
Plasma half-life · hours
Does not process in equines
Equine dosing
No value in horses - does not metabolize
Cmax · peak plasma concentration
Unavailable
Tmax · time to peak plasma concentration
Unavailable
ESC concentration guidance
Lowest Dectable Level (LDL) 0.05 mg/mL or 50 picograms per mL
Primary withdrawal · hours
12
Washout withdrawal · hours
168
ESC control type
C1 - Strictly Controlled - Restricted - Performance
Medication report required
MED REPORT REQUIRED

Uses & side effects

Drug interactions

Corticosteroids in equines carry high-risk drug interactions that can trigger severe gastrointestinal ulcers, profound insulin spikes, or acute laminitis. Because corticosteroids (such as dexamethasone, triamcinolone, and prednisolone) are powerful systemic anti-inflammatories, they alter metabolic, gastrointestinal, and immune systems across the entire horse.When combined with specific medications, these changes can rapidly amplify life-threatening equine pathologies.⚠️ Critical & Dangerous Interactions1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)The Interaction: Combining systemic corticosteroids with standard equine NSAIDs like phenylbutazone (Bute), flunixin meglumine (Banamine), or firocoxib (Equioxx) is strongly contraindicated.The Risk: Both drug classes heavily suppress the production of protective prostaglandins in the horse's stomach and right dorsal colon. Stacking them completely strips the mucosal lining of its defense mechanisms, dramatically increasing the risk of severe gastric ulcers, internal bleeding, and toxic Right Dorsal Colitis.2. Potassium-Depleting DiureticsThe Interaction: Co-administering corticosteroids with strong diuretics such as furosemide (Salix/Lasix), which is regularly used in racehorses to manage Exercise-Induced Pulmonary Hemorrhage (EIPH).The Risk: Both drugs force the equine kidneys to flush potassium. Combining them can cause severe, dangerous hypokalemia (critically low blood potassium levels), resulting in muscle weakness, cardiac arrhythmias, and metabolic imbalances.3. Fluoroquinolone AntibioticsThe Interaction: Concurrent use of corticosteroids with fluoroquinolone antimicrobials like enrofloxacin (Baytril).The Risk: In veterinary medicine, this specific combination is noted for altering the cellular structure of collagen. It significantly elevates the risk of tendon or ligament weakness and rupture.🔄 Metabolic & Pathological Interactions1. Metabolic Medications & SGLT2 InhibitorsThe Interaction: Corticosteroids interact heavily with medications used to manage Equine Metabolic Syndrome (EMS) or Pituitary Pars Intermedia Dysfunction (PPID/Cushing's), such as pergolide (Prascend) or ertugliflozin.The Risk: Corticosteroids naturally provoke severe insulin resistance and transient hyperglycemia. If a horse with underlying EMS is given a corticosteroid (even a localized joint injection like triamcinolone), it can cause a "profound" insulin spike—sometimes surging past 200 μU/mL—directly inducing hyperinsulinemia-associated laminitis (HAL). Recent studies show that SGLT2 inhibitors like ertugliflozin can help blunt this dangerous metabolic spike, but combining these therapies requires strict veterinary oversight.2. Vaccines and ImmunomodulatorsThe Interaction: Administering core equine vaccines (e.g., West Nile, Tetanus, Rabies) while a horse is on a course of corticosteroids.The Risk: Corticosteroids reduce the function of infection-fighting white blood cells (neutrophils and lymphocytes). Giving a vaccine during steroid therapy suppresses the horse's immune system, preventing it from building an adequate protective antibody response and rendering the vaccine ineffective.📉 Drug Clearing & Efficacy InteractionsLiver Enzyme Inducers (Rifampin, Phenobarbital): If a horse is treated with the antibiotic rifampin (commonly used for Rhodococcus equi in foals) or phenobarbital for seizures, these drugs accelerate the liver's metabolic pathways. This causes the horse's body to process and clear corticosteroids far too rapidly, severely reducing the steroid's therapeutic effectiveness.🚫 Regulatory and Testing RestrictionsCorticosteroids are tightly regulated "Controlled Substances" by equestrian governing bodies, including US Equestrian (USEF) and the Equine Sports Council (ESC). Because they modify performance and mask joint pain, even localized joint injections or topical eye/skin ointments can easily trigger a positive drug test. A precise veterinary-calculated withdrawal period must be strictly enforced before entering any sanctioned competition.

Contraindications

Government Numbers

Hikma prednisone tablets: human prescription product; ANDA 080352. The 5 mg product has NDC 0054-9828-25 (100 tablets) and 0054-9828-31 (1,000 tablets). This label does not establish equine approval or equine dosing. Label updated April 22, 2025; reviewed September 18, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=263ed4fa-3c29-4abb-9cb1-bc016bd34a05

Sanctioning-body comparison

Plasma only. Compare published competition guidance for this medication. ESC guidance remains in Medication Facts above. A dosing guideline, withdrawal recommendation and laboratory detection threshold are different measures.

Sources reviewed September 23, 2026. “Not verified” means a gap in this comparison, not zero tolerance or permission. Doses describe the cited rules; your veterinarian must determine treatment and withdrawal.

Published guidance by organization
OrganizationPublished dose & routePlasma concentrationWithdrawal / timingControl / penalty class
AQHA Show HorsesShow rules · 2026 handbook
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules.

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Medication-specific control not yet verified.
APHA Paint Show HorsesShow rules · 2026 Rule Book
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules.

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Medication-specific control not yet verified.
ARCI Model RulesRacing model · Rules 15 / UCG 20.0 / CTMS 4.2.1
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules. ARCI model comparison only; no state-specific rule is substituted. Schedule timing is tied to its stated regimen and is not a clearance guarantee.

UCG 20.0 PDF p. 48

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Drug Class 4 · Penalty Class C. No dosing permission is implied by classification.
USEFNational Therapeutic Substance Provisions · 2026 + July amendment
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules.

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Medication-specific control not yet verified.